Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Int J Cancer. 2018 Feb 7;142(11):2293–2302. doi: 10.1002/ijc.31266

Appendix Table 1.

Distribution of general, combined, and progestin-only oral contraceptive use and missing values according to study population at baseline and follow-up – The NOWAC Study

Study population at baseline (n = 74,862) Study population at follow-up (n = 51,850)
General OC use, no. (%)
Never use 26,251 (35.1) 18,073 (24.1)
Ever use 48,611 (64.9) 33,777 (45.1)
 Current use 5,361 (7.2) 1,956 (2.6)
 Former use 43,250 (57.8) 31,821 (42.5)
Missing 0 (0) 23,012 (30.7)
Duration (years) of OC use1
 1–4 26,656 (35.6) 18,598 (24.8)
 5–9 12,246 (16.4) 8,490 (11.3)
 ≥ 10 8,529 (11.4) 5,851 (7.8)
Missing 1,180 (1.6) 23,850 (31.9)
Time (years) since last OC use1
 < 10 16,430 (22.0) 5,569 (7.4)
 11–20 22,077 (29.5) 12,949 (17.3)
 > 20 8,811 (11.8) 14,637 (19.6)
Missing 1,293 (1.7) 23,634 (31.6)
COC use, no. (%)
Never use 38,896 (52.0) 26,738 (35.7)
Ever use 35,966 (48.0) 25,112 (33.5)
 Current use 3,239 (4.3) 950 (1.3)
 Former use 32,727 (43.7) 24,162 (32.3)
Missing 0 (0) 23,012 (30.7)
Duration (years) of COC use1
 < 5 19,765 (26.4) 13,992 (18.7)
 ≥ 5 16,201 (21.6) 11,120 (14.9)
Missing 0 (0) 23,012 (30.7)
POC use, no. (%)
Never use 65,771 (87.9) 44,737 (59.8)
Ever use 9,091 (12.1) 7,113 (9.5)
 Current use 968 (1.3) 379 (0.5)
 Former use 8,123 (10.9) 6,734 (9.0)
Missing 0 (0) 23,012 (30.7)
Duration (years) of POC use1
 < 5 6,862 (9.2) 5,423 (7.2)
 ≥ 5 2,229 (3.0) 1,690 (2.3)
Missing 0 (0) 23,012 (30.7)

COC = Combined oral contraceptives; OC = Oral contraceptives; POC = Progestin-only contraceptives.

1

Among ever-users.